Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Saroglitazar (4mg) Tablet
Therapeutic Category
Antidiabetic, Cardiology, Diabetic
Dosage Form
Tablet
Packaging Type
Bottle
Packaging
45 Tablet
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Sarogit 4 Tablet containing Saroglitazar is used for the management of diabetic dyslipidemia. It helps in controlling high triglyceride levels, improving lipid profile, and supporting better blood sugar control in patients with type 2 diabetes.
Saroglitazar works by regulating lipid metabolism and improving insulin sensitivity, helping manage both cholesterol abnormalities and glucose levels. This dual action supports better metabolic balance and reduces cardiovascular risk.
The tablet is widely prescribed in chronic diabetic patients who require long-term lipid and sugar control, leading to consistent repeat prescriptions and steady demand in the market.
With rising diabetes cases and increasing awareness of lipid management, this product offers strong business potential for distributors and retailers. Its dual-benefit therapy, regular prescription flow, and long-term usage pattern make it a high-demand product that supports consistent sales and growth in the diabetic care segment.
Some patients may experience weakness, fatigue, gastritis, or mild elevation in liver enzymes. Rarely, edema, weight gain, or muscle-related symptoms may occur and should be evaluated by a healthcare professional.
Sarogit 4 Tablet is indicated for the management of diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes mellitus. It helps lower elevated triglyceride levels, improve overall lipid profile, and support glycemic control, thereby reducing the risk of cardiovascular complications.
This medicine should be used under medical supervision. Regular monitoring of liver function is recommended during treatment. Patients with liver disease or those taking other antidiabetic or lipid-lowering agents should consult their doctor before use.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sarogit 4 Tablet, containing Saroglitazar 4mg, has strong demand in the diabetic and metabolic care segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their chronic care and cardiometabolic portfolio.
Medical distributors and agencies can benefit from the increasing market demand for medicines used in diabetic dyslipidemia, hypertriglyceridemia, and metabolic disorder management. Sarogit 4 Tablet helps strengthen a comprehensive diabetic and metabolic care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sarogit 4 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted diabetic and metabolic care product range when partnering for Sarogit 4 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Sarogit 4 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.